In the research on multiple opioid receptors, the characterization of opioid alkaloids as hgands for the postulated p and K types of receptor has been hampered by the considerable cross-reactivity of these compounds, particularly pronounced in membranes of the rat brain (Kosterlitz and Paterson, 1980; Pfeiffer and Hem, 1981; Magnan, Paterson, Tavani and Kosterlitz, 1982) . Although lately some novel alkaloids have been described which exhibited distinct K activity in bioassay systems (Romer, Hill and Maurer, 1982; von Voigtlander, Lahti and Ludens, 1983; Lahti, Mickelson, McCall and von Voigtlander, 1985) , ethylketocyclazocine (EKC) has widely been used as a K agonist in studies of ligand binding to opioid receptors in membranes of the rat brain (Hiller and Simon, 1980; Pasternak, 1980; Snyder and Goodman, 1980; Chang, Hazum and Cuatrecasas, 1980) . However, the shortcomings of this opiate and of the brain of the rat as the ligand and tissue of choice to' characterize the K opioid receptor have recently been emphasized (Goldstein and James, 19&1) . Indeed, apparently due to the lack of selectivity, the findings of early binding studies have failed to substantiate the existence of separate receptors for narcotic drugs of the K type in the brain of the rat. Subsequently, partial support for discrete K sites in rat brain was obtained from simultaneous computer analysis of the binding of labelled p and K opiates (Pfeiffer and Herr, 1982) and from competitive ligand displacement in brain membranes from the rat (Chang, Hazum and Cuatrecasas, 1981; Wolozin, Nishimura and Pastemak, 1982) and mouse (Garzon, SanchezBlazquez and Lee, 1984) .
Recently, it has been possible to differentiate between putative h and K opiates on the basis of their responses to sodium in displacing 13HJEKC and [3H~to~hine in membranes from rat and pigeon brain (Med~hra~ky, Dahlstrom, Woods, Fischel and Mitsos, 1984) . The biphasic nature of the binding of opiate alkaloids in membranes from the brain of the rat has also been described and the strong influence of methodology on the outcome oi the kinetic analysis of opioid receptor binding has been demonstrated (Fischel and Medzihradsky, 1981) . As a follow-up to these studies, the present work has investigated the interaction between [3H] EKC and opioid receptors in membranes from the brain of the rat under conditions of (a) equilibrium binding, (b) association and dissociation, and (c) competitive inhibition by different opioid alkaloids. The aim was to probe the resolution of the binding of K opioid receptors in membranes of the rat brain, obtainable by the kinetic approach with EKC as the prototype ligand. For comparative purposes, the relevant properties of tritiated etorphine, an opiate with broad specificity in binding to opioid receptors, were also investigated.
METHODS

Materials
['H]Ethylketocyclazocine
(15 Ci/mmol) and [3H] etorphine (39 Ci/mmol) were purchased from New England Nuclear Co., Boston, Massachusetts, U.S.A. and Amersham Corp., Arlington Heights, Illinois, U.S.A., respectively. The radiochemical purity of these compounds was 98%, as ascertained by thinlayer chromatography on silica gel G plates (Eastman Kodak Corp., Rochester, New York, U.S.A.) in two different solvent systems recommended by the manufacturers.
The uniabelled opiates were obtained through the Drug Abuse Basic Research Center at The University of Michigan. The enantiomers (1 R, 5R, 9R, 2'R)-5,9-dimethyl -2" -tetrahydrofurfuryl-6,7 -benzomorphan (UMl071-R) and the all-S isomer of UM1071-R (UMl071-S) are N-furyl-substituted benzomorphans with widely diverging K agonist activity (Medzihradsky et al., 1984; Woods, Smith, Medzihradsky and Swain, 1979) , and were used in this study as the pharmacologically active and inactive isomer, respectively. 5,9-Diethyl-2-(3-furylmethyl)-2'-hydroxy-6,7benzomorphan (MR2266) is a N-furylsubstituted benzomorphan antagonist that was classified as a K opiate (Woods et al., 1979) , but in different studies had varying potency toward p and K agonists (Lord, Waterfield, Hughes and Kosterlitz, 1977; Barchfeld, Maassen and Medzihradsky, 1982) . Biochemical agents were purchased from Sigma Chemical Co., St Louis, Missouri, U.S.A. Other compounds were of reagent grade, and were obtained from commercial distributors of chemicals.
Isolation and pretreatment of membranes
Parts of this procedure have been published previously (Fischel and Medzihradsky, 1981) . Male, Sprague-Dawley rats weighing 200g were decapitated and the cerebra pooled in 100 vol of ice-cold 50 mM Tris-HCl buffer, pH 7.4. After disrupting the tissue using a Polytron homogenizer, the resulting homogenate was centrifuged at 20,000 g for 15 min at 4°C. The pellet was resuspended in the same volume of the Tris buffer using a Dounce homogenizer. Aliquots of this suspension, sufficient for one experiment, were frozen at -70C.
The concentration of protein in these samples was approx. 0.6 mgjml and opiate receptor binding was shown to be stable under such conditions for at least 6 months.
Upon thawing, the membranes were suspended in a Dounce homogenizer and used as such, or were subjected to an initial incubation. In the latter case. the membranes were centrifuged at 20,OOOg for 15 min, the pellet was resuspended in 50 mM Tris-HCl buffer, pH 7.4 at 37°C and the suspension then incubated at 37°C for 40 min. After a repeated centrifugation at 20,OOOg for I5 min at 4"C, the pellet was resuspended in the appropriate buffer medium for the assay of receptor binding. Unless otherwise specified, the buffer was 50mM Tris-HCl, adjusted to pH 7.4 at the assay temperature.
Analysis of receptor binding at equilibrium
To 8 ml polypropylene tubes in an ice-water bath, were added 400~1 membrane suspension (approx. 200 pg protein), 50 ~1 distilled water or 50 ~1 1,575 M NaCl (final concentration in assay 150 mM) and 50 ~1 distilled water or solution of unlabelled drug. Unless specified otherwise, the assay mixture was incubated in a shaking water bath for 15 min at 25°C. After the addition of 25 ~1 aliquots of the radiolabelled ligand, the assay tubes were incubated to reach equilibrium in ligand binding and then either placed in an ice-water bath for 10 min or filtered directly. Prior to use, the Whatman GF/C filters employed were soaked in distilled water and washed on the filter assembly three times with 5 ml aliquots of distilled water saturated with amyl alcohol (Medzihradsky, 1976) . The tube and the filtered material were rinsed with three 4ml aliquots of ice-cold 50 mM Tris-HCl, pH 7.4. The filters were transferred into scintillation vials, 1 ml of absolute ethanol and 10 ml of a dioxane-xylene-napththalene scintillation mixture were added and the samples subjected to liquid scintillation counting. Average counting efficiency was 36% as determined by the use of 'HzO.
The actual concentration of tritiated drug present in the assay medium was determined by counting aliquots of the corresponding stock solution prepared for that particular experiment. Specific, i.e. receptorrelated, interaction of the radiolabelled ligand was determined either with a stereospecific "binding window" (Fischel and Medzihradsky, 1981) established for [3H] EKC with the active and inactive isomers UMl071-R/UMl071-S and for [-'H] etorphine with levorphanol/dextrorphan, or was defined as the difference in binding obtained in the absence and presence of IO p M unlabelled ligand.
Analysis of receptor binding kinetics
These experiments were performed as described above with the following exceptions. To determine the rates of ligand-receptor association, the assay was terminated at various times before and after binding equilibrium.
The kinetics of ligand-receptor dissociation were assessed by the method of "infinite dilution" (DeMeyts, Bianco and Roth, 1976) , i.e. the reassociation of the radiolabelled ligand with the receptor was prevented by dilution in the presence of excess unlabelled ligand. Membrane suspensions were incubated with a tritiated opiate to equilibrium, centrifuged at 20,000 g at 4°C for 15 min, and rapidly suspended in 2 ml of ice-cold 50 mM Tris-HCl, pH 7.4 at 25°C. Ligand dissociation was initiated by the addition of 50~1 aliquots of this suspension to tubes containing 5 ml of prewarmed (25°C) 50 mM Tris-HCI buffer, pH 7.4, with or without 1 PM unlabelled ligand. Samples were filtered at the time of this addition (defined as 100% binding) and at various times thereafter.
Determination of protein
The method of Lowry et al. was applied (Lowry, Rosebrough, Farr and Randall, 1951) . Standards of crystalized, lyophilized bovine serum albumin were prepared using the same buffer medium present in the biological samples being tested, unless it was demonstrated experimentally that the components of the medium did not interfere with the protein assay (Peterson, 1979) .
Methods of computer analysis and statistical evaluation
The results from both equilibrium binding and kinetic experiments were evaluated using NONLIN, a weighted nonlinear least-squares regression analysis program (Metzler, 1969) . The data were weighted according to the inverse of the observed experimental values (Boxenbaum, Riegelman and Elasoff, 1981) and were fitted to one or more of the appropriate equations listed in Table 1 . Initial estimates for binding parameters were obtained from the respective double reciprocal plots (Neal, 1972) , or by using CSTRIP, a computerized feathering technique for obtaining estimates from multiphasic exponential curves (Sedman and Wagner, 1976) . The appropriateness of a binding mode1 was assessed by the distribution of the weighted residuals about the theoretical curve and by the extent to which the sum of the weighted squared deviations was minimized. The significance of differences between the binding models was evaluated statistically using the F-ratio test (Table 2 ). Statistical differences between the calculated binding constants or between the means of various experiments were evaluted using a two-tailed Student's t-test (Boxenbaum et al., 1981) .
RESULTS
Equilibrium binding
Specific binding of ['H]EKC, determined within the linear range of membrane protein dependence, reached equilibrium after 40 min at 25"C, both in the absence and presence of sodium. In agreement with the results of previous studies (Simon, Hiller and Edelman, 1973; Tolkovsky, 1982) , steady-state in the receptor binding of (3H] etorphine was obtained after 20min incubation at 25°C. Scatchard analysis of specific binding of [3H] EKC revealed (Fig. 1A) that the presence of 150 mM NaCl decreased the number of high-affinity binding sites by 50% with no changes in the corresponding K, (Table 2) . Prior incubation of the membranes increased the number of highaffinity binding sites 1.6-fold without altering the K, either in the presence or absence of Na+. Thus, the pretreatment did not change the numerical value of the sodium ratio in [)H]EKC binding (binding in the absence of Na+/binding in the presence of Na+). Neither initial incubation of membrane nor Na+ altered the interaction between [)H]EKC and the low-affinity specific binding sites. Computer analysis demonstrated that the model, consisting of two noninteracting saturable binding sites (Table l) , provided the best fit for the data obtained (Table 2) . Although no statistically-significant difference between the twosaturable-site model and the one-cooperative-site mode1 was obtained in the presence of NaCl, dissociation experiments, using the method of infinite dilution, revealed the lack of cooperative interactions (data not shown). Specific binding, determined by excess of unlabelled ligand, was completely stereospecific as shown by the use of UMIO'Il-R, a potent K agonist and its virtually inactive enantiomer UM1071-S as displacing agents (Fig. 1, inset) .
As described above for the receptor binding of ['HIEKC, Scatchard analysis and computer fitting to binding modets resolved specific binding of ['Hletorphine into two components with no evidence of negative cooperativity (Fig. 1 B) . The respective Ko values (nM) in the absence and presence of Na+ were 0.13 f 0.02 and 22 + 7 for ['HIEKC, and 0.06 * 0.03 and 5.3 + 2.2 for ['Hletorphine. The corresponding values for n, and n2 (fmol/mg protein) were 220 + 1 I and 289 f 24, while with Na+ they were 114 + 22 and 177 + 24. As was the case for ['HIEKC, prior incubation of the membrane did not alter the extent of the sodium ratio for [3H] etorphine (data not shown). The slight, statistically-insignificant, discrepancies in the numerical values of the binding parameters for the high-affinity site listed in Tables 2 and 4 are due to different modes of fitting the data.
Competitive interactions assessed at equilibrium
Various concentrations of the radiolabelled ligand were incubated in the absence and presence of a constant concentration of a given unlabelled opiate (Table 4 ). The latter concentration was selected to inhibit the specific binding of 0.5 nM radiolabelled ligand by 30-50%. Initially, the results were evaluated by computer analysis for binding to a twosaturable-site model. Since no statistically-significant inhibition of the low-affinity binding site was observed, the data for all experiments within a given set of conditions (e.g. inhibition of radiolabelled ligand binding in either the absence and presence of NaCl) were fitted simultaneously, assuming no changes in the binding parameters of the low-affinity binding site. This approach has increased the statistical precision in evaluating the kinetic constants of the high-affinity binding sites. The uniabelled opiates increased the apparent Kus 2-to 7-fold for [3H] 3H] etorphine. These experiments were carried out at 25°C in the absence (0) or presence (0) of 15OmM NaCl with cerebral membranes which had been subjected to prior incubation. To investigate the association kinetics, specific binding of 0.5 nM of ['HI-EKC (A) or [3HJetorphine (C) were determined as described in Methods. The ordinate represents the natural logarithm of the specific binding at equilibrium divided by the difference between that quantity and the specific binding at the times indicated (Bennett, 1978) . In the experiments on ligand dissociation, the membrane suspension was incubated with 0.5nM of [3H] between both p and K opiates at the high-affinity binding sites for the radiolabelled ligands (Table 4) .
Kinetics of ligand binding and dissociation
The rates of association and dissociation of ['HJEKC and [3H] etorphine revealed two phases ( Fig. 2 and Table 3 ) of the high-affinity ligandreceptor interaction, which appeared homogeneous under conditions of equilibrium binding ( Fig. 1 and Table 2 ). Both in the absence and presence of Na+ the two phases were characterized by fast and slow equilibration, respectively. The Kn values calculated from the respective rate constants were similar to those obtained for the high-affinity binding sites from the data of the equilibrium binding experiments (Tables 2 and 3 , and text).
Competitive ligand dissociation
In these experiments, the interaction between different opiates and the two'dissociating phases of [3H] EKC (not shown) and ['Hletorphine binding The listed data are the computer-estimated values for the experiments described in Fig. 2. K,,, , is defined as k-,/k, or k-,/k, (Fig. 3) (Table 4 ). In the absence of NaCl, competing opiates altered the relative contribution of the slowly-and rapidlydissociating components to total specific binding of ['H]EKC and [3H] etorphine: significantly greater inhibition of the slow component occurred. However, the extent of inhibition by putative p and K ligands was indistinguishable (Fig. 3) . On the other hand, in the presence of Na+, a differential effect of fl and K opiates on the dissociation of [3H] etorphine (but not of ['H]EKC) became apparent. Whereas p agonists reduced the contribution of the slow component to specific binding at equilibrium from 53 to 35%, K agonists had little or no effect. Putative antagonists of either type of opioid receptor produced no significant changes in the distribution of the two dissociative phases (Fig. 3) .
DISCUSSION
Analysis of nonlinear receptor binding.
Biphasic specific binding of opiates, as shown in this study for etorphine, has frequently been ascribed to the presence of two different populations of receptor sites. However, other biological (DeMeyts, Roth, Neville, Gavin and Lesniak, 1973) or methodological (Fischel and Medzihradsky, 1981) factors can be responsible for such findings. Negatively cooperative ligand-receptor interactions were shown to be responsible for the biphasic binding of insulin to a variety of tissues (JDeMeyts et al., 1976 ). This conclusion was based primarily on the ability of unlabelled insulin to accelerate the dissociation rate of previously bound [iZSI] insulin (DeMeyts et al., 1973) . By this criterion, as well as by the "goodness of fit" of the data to allosteric or multiple site models by a computer-modelling procedure, the opioid receptor binding of ['H]EKC and ['Hletorphine in the present work was shown to be best described by two populations of non-interacting saturable binding sites with different affinities, rather than by an occupancy-dependent isomerization of a single site (Tolkovsky, 1982) . In contrast to the receptor model with distinctive non-interacting binding sites for the opioid alkaloids investigated in this work, the binding of morphine and leucine enkephalin in membranes from the rat brain was best described by two allosterically-coupled populations of sites Westfall, 1982a, 1982b) . According to that model, the binding of morphine (and etorphine) masks, and thus modulates, the binding sites for the opioid peptide. A similar model, depicting allosteric interaction between K and b opioid ligands binding to different sites on a common recep tor molecule (endorphin receptor), has also been proposed (Smith and Lee, 1983) . It is of interest to point out that these allosteric models of the opioid receptor are based on the binding patterns of pairs of chemically-dissimilar ligands, i.e. an alkaloid and peptide. In contrast, in the previous study (Fischel and Medzihradsky, 1981) and present work, the receptor binding of opioid alkaloids has been described, whereby the data favored a two-site rather than an allosteric model. A recent kinetic study of the binding of opioid agonists and antagonists in membranes from the rat brain has shown that opioid alkaloids, in contrast to opioid peptides, interact with multiple receptor sites (Scheibe, Bennett, Spain, Roth and Coscia, 1984) .
The kinetics of receptor binding carried out in this study confirmed the relevance of the proposed model and provided further resolution.
The kinetic data revealed that high-affinity ligand binding consisted of two components, equilibrating at different rates, not distinguishable by equilibrium binding methods. Using [3HXD-AlaZ-D-LeuS)enkephalin, a slowly dissociating ligand-opioid receptor complex has previously been described in synaptic membranes from bovine brain (Pryhuber, Roth and Coscia, 1982) . This observation has led to the postulation of a multistep mechanism for opioid agonists, whereby the rapidly reversible ligand-receptor complex initially formed is converted into a slowly-dissociating high-affinity conformation (Scheibe et al., 1984) . The comparison of these findings with the present data is hampered by the use of opioid agonist peptides in one and alkaloids in the other. Nonetheless, in apparent contrast to the multistep binding model for agonists, multiple dissociation components for the antagonist [3H] naltrexone have also been described (Fischel and Medzihradsky, 1981) . It should also be noted that similar Kr, values for the receptor binding of t3H'Jnaltrexone (Fischel and Medzihradsky, 1981) , [%JEKC and [3H] etorphine (see Results) were obtained at equilibrium and kinetically. However, in neither study an occupancy-dependent shift in ligand binding affinity and pattern of dissociation has been specifically tested for.
Sign$cance of high and low ajinity binding sites
In early studies on opioid receptor binding, the marked depression of the high-affinity component for [3H] dihydromorphine in the presence of sodium ions led to the suggestion that antagonists and agonists bind to the high and low-affinity sites, respectively (Pasternak and Snyder, 1975) . However, subsequently pure opioid agonists were shown to displace high-affinity binding sites (Lord et al., 1977) .
Indeed. as shown in this study, both agonists and antagonists competed preferentially for the highaffinity binding sites (Table 4) . In this respect the present data, obtained with membranes from rat brain, provide no support for the recently proposed receptor model of separate recognition sites for opioid agonists and antagonists (Portoghese and Takemori, 1983) .
In membranes from transformed neural cells, unlabelled IC and 6 opiates competed preferentially with the low-affinity component of the ['H]EKC binding isotherm (West, McLawhon, Dawson and Miller, 1981) . Correspondingly, it was proposed that the high-affinity binding site, termed p,, is common to all opiates and. is responsible for analgesia, whereas ligand interaction at the lower affinity receptor sites mediates the specific effects of the different types of opiates (Pasternak, 1980; Wolozin et al., 1982) . On the other hand, the results in this paper show that in membrane preparations from rat cerebra, a partial resolution in the dissociation of p and K opiates was achieved at ligand concentrations which favored the binding to the high-affinity sites of [3H] EKC and [3H] etorphine.
Discrimination between the receptor binding of [3H]EKC and [3H]erorphine
The classification of p and IC opiates in membranes from the rat brain has recently been described on the basis of their differential sensitivity toward sodium ions in binding to receptor . A possible molecular correlate for this resolution was revealed by the kinetics of ligand binding determined in the present study. The high affinity binding of ['H]EKC and ['Hletorphine consisted of two components. In the presence of sodium, the rapidly-dissociating phase of OH]etorphine binding became refractory to inhibition by p but not K agonists, thus revealing a degree of discrimination between these types of opiates at the high-affinity binding sites. Since the unlabelled opiate alkaloids altered the relative contribution of the rapidly and slowly equilibrating components to total ligand binding without affecting the respective dissociation rates, their interaction with receptor was competitive rather than cooperative in nature. In view of the different ["HIEKC and ['Hletorphine was inhibited by both p and K opiates, it would have been tempting to assume that it represents the nI sites, and the rapidly equilibrating component the K binding sites. However. in such a case one of the dissociative components of [3H] EKC should have been insensitive to inhibition by p agonists. To what extent conformational changes between receptor forms of different affinity (Scheibe et al., 1984) represent a general phenomenon for the binding of opioid ligands remains to be assessed. A higher degree of resolution of the K receptor in membranes from the rat brain can be expected from the use of either radiolabelled opiates with increased specificity (e.g. von Voigtlander et al., 1983; Lahti et al., 1985) or unlabelled irreversible ligands specifically alkylating discrete populations of opioid receptor sites Clark and Medzihradsky, 1986 ). An alternative and comprehensive approach is the study of opioid receptor heterogeneity in systems where receptor-effector coupling represents an additional molecular diversity which contributes to the biological differentiation of the action of opiates (Barchfeld et al., 1982; Barchfeld and Medzihradsky, 1984; Clark and Medzihradsky, 1986) . In this respect, the heterogeneity of opioid receptors can be expressed by the nature of the effector system, and the mechanism and efficacy of coupling. However, the results of this study show that even under conditions of unfavorable ligand and tissue specificity, the analysis of ligand association and dissocation kinetics, in addition to the assessment of equilibrium binding, represents a valuable approach in characterizing the interaction between ligands and opioid receptors.
